mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.0043 |
0.9 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
0.0042 |
0.9 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.004 |
0.9 |
mRNA |
RO4929097 |
CTRPv2 |
pan-cancer |
AAC |
0.0059 |
0.9 |
mRNA |
XL765 |
CTRPv2 |
pan-cancer |
AAC |
0.0042 |
0.9 |
mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
-0.0036 |
0.9 |
mRNA |
Salubrinal |
GDSC1000 |
pan-cancer |
AAC |
0.0057 |
0.9 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
mRNA |
QL-XII-61 |
GDSC1000 |
pan-cancer |
AAC |
-0.0051 |
0.9 |
mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
0.0038 |
0.9 |